Latest Takeda Biopharmaceuticals India News & Updates

New Delhi, July 20 (IANS) India has approved its first dengue vaccine, with the Drug Controller General of India (DCGI) granting market authorisation to Takeda Biopharmaceuticals India’s QDENGA, marking a significant milestone in the country’s efforts to combat one of its most widespread mosquito-borne diseases, it was announced on Monday.The vaccine has been approved for individuals aged between 4 and 60 years and can be administered irrespective of whether a person has previously been infected…